Cite Filings / COCP / 0001493152-26-036650

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Cocrystal Pharma, Inc. Filed 2026-08-07 Acc 0001493152-26-036650

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-11-06 SCHEDULE 13D/A Beneficial Ownership Report
2026-08-07 SCHEDULE 13D/A Beneficial Ownership Report
2026-08-07 SCHEDULE 13D Beneficial Ownership Report
2026-08-06 4 Director bought 10,000 shares at $0.98 ($9,816)
2026-08-05 4 Director bought 75,000 shares at $0.94 ($70,590)
2026-08-03 8-K Material agreement · Unregistered share sale · Regulation FD disclosure
2025-10-30 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…